Clinical Trial Update: Efficacy of Quetiapine in Generalised Social Anxiety Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating quetiapine for generalized social anxiety disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Social Anxiety Disorder | Phase 3 | Status: TERMINATED